Fancher Tonya L, White Richard H, Kravitz Richard L
Division of General Medicine, University of California at Davis, Patient Support Services Building, Suite 2400, Sacramento, California 95817, USA.
BMJ. 2004 Oct 9;329(7470):821. doi: 10.1136/bmj.38226.719803.EB. Epub 2004 Sep 21.
To summarise the evidence supporting the use of rapid d-dimer testing combined with estimation of clinical probability to exclude the diagnosis of deep venous thrombosis among outpatients.
Medline (June 1993 to December 2003), the Database of Abstracts and Reviews (DARE), and reference lists of studies in English.
We selected 12 studies from among 84 reviewed. The selected studies included more than 5000 patients and used a rapid D-dimer assay and explicit criteria to classify cases as having low, intermediate, or high clinical probability of deep vein thrombosis of the lower extremity among consecutive outpatients.
Diagnosis required objective confirmation, and untreated patients had to have at least three months of follow up. The outcome was objectively documented venous thromboembolism. Two authors independently abstracted data by using a data collection form.
When the less sensitive SimpliRED D-dimer assay was used the three month incidence of venous thromboembolism was 0.5% (95% confidence interval 0.07% to 1.1%) among patients with a low clinical probability of deep vein thrombosis and normal D-dimer concentrations. When a highly sensitive D-dimer assay was used, the three month incidence of venous thromboembolism was 0.4% (0.04% to 1.1%) among outpatients with low or moderate clinical probability of deep vein thrombosis and a normal D-dimer concentration.
The combination of low clinical probability for deep vein thrombosis and a normal result from the SimpliRED D-dimer test safely excludes a diagnosis of acute venous thrombosis A normal result from a highly sensitive D-dimer test effectively rules out deep vein thrombosis among patients classified as having either low or moderate clinical probability of deep vein thrombosis.
总结支持采用快速D - 二聚体检测结合临床概率评估以排除门诊患者深静脉血栓形成诊断的证据。
医学期刊数据库(1993年6月至2003年12月)、摘要与综述数据库(DARE)以及英文研究的参考文献列表。
我们从84篇综述中选取了12项研究。所选研究纳入了5000多名患者,并采用快速D - 二聚体检测及明确标准,将连续门诊患者下肢深静脉血栓形成的临床概率分为低、中、高。
诊断需客观证实,未治疗患者必须至少随访3个月。结局为客观记录的静脉血栓栓塞。两位作者使用数据收集表独立提取数据。
当使用敏感性较低的SimpliRED D - 二聚体检测时,深静脉血栓形成临床概率低且D - 二聚体浓度正常的患者中,静脉血栓栓塞的3个月发生率为0.5%(95%置信区间0.07%至1.1%)。当使用高敏感性D - 二聚体检测时,深静脉血栓形成临床概率低或中等且D - 二聚体浓度正常的门诊患者中,静脉血栓栓塞的3个月发生率为0.4%(0.04%至1.1%)。
深静脉血栓形成临床概率低且SimpliRED D - 二聚体检测结果正常可安全排除急性静脉血栓形成的诊断。高敏感性D - 二聚体检测结果正常可有效排除深静脉血栓形成临床概率低或中等的患者的深静脉血栓形成诊断。